← Back to Search

Procedure

S-LPC:Selective Laser Photocoagulation for Twin to Twin Transfusion Syndrome (TTTS Trial)

N/A
Waitlist Available
Led By Giancarlo Mari, M.D., MBA
Research Sponsored by University of Tennessee
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
The device will be used in multifetal pregnancies affected with twin-to-twin transfusion syndrome (TTTS) at less than 27 weeks of gestation
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up the device will be used in multifetal pregnancies affected with twin-to-twin transfusion syndrome (ttts) at less than 27 weeks of gestation;procedure will last approx 1 hour
Awards & highlights

Summary

Humanitarian use device (HUD): Use of the fetoscopy instrument sets for selective laser photocoagulation in the treatment of Twin to Twin Transfusion Syndrome (TTTS).

Eligible Conditions
  • Twin to Twin Transfusion Syndrome

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~the device will be used in multifetal pregnancies affected with twin-to-twin transfusion syndrome (ttts) at less than 27 weeks of gestation;procedure will last approx 1 hour
This trial's timeline: 3 weeks for screening, Varies for treatment, and the device will be used in multifetal pregnancies affected with twin-to-twin transfusion syndrome (ttts) at less than 27 weeks of gestation;procedure will last approx 1 hour for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Laser ablation of placental anastomoses for treatment of severe TTTS and establishment of normalized blood flow between the fetal twins.

Trial Design

1Treatment groups
Experimental Treatment
Group I: S-LPC:Selective Laser PhotocoagulationExperimental Treatment1 Intervention
S-LPC seals connecting vessels, normalizes flow between twins
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
S-LPC:Selective Laser Photocoagulation
2010
N/A
~10

Find a Location

Who is running the clinical trial?

University of TennesseeLead Sponsor
192 Previous Clinical Trials
144,103 Total Patients Enrolled
Regional Medical Center, Regional One HealthUNKNOWN
Giancarlo Mari, M.D., MBAPrincipal InvestigatorProf. & Chair, UTHSC; Dir.,TN Inst. of Feto-Maternal & Infant Health; Dir., High-Risk Obstetrics Ctr of Excell., Regional Medical Ctr
1 Previous Clinical Trials
500 Total Patients Enrolled
~0 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top